ENTOD PHARMACEUTICALS LIMITED
Location
Maharashtra
Founded
1981-10-31
Website
Risk Signals
47 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Industrial Organic Chemicals, Not Elsewhere Classified, Special Industry Machinery, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about ENTOD PHARMACEUTICALS LIMITED
Live alerts from global media, monitored by Business Radar
2025-04-25 (expresspharma.in)
ENTOD Pharmaceuticals receives CDSCO approval for paediatric myopia treatment -
The formulation, approved following Phase 3 trials in India, becomes the first globally authorised treatment strength for slowing myopia progression in children aged 6 to 12 years
Read more
2024-09-26 (thehindu.com)
Eye drops for presbyopia: Pharma firm meets Drug Controller General of India, issues clarification
ENTOD Pharmaceuticals addresses concerns with PresVu eye drops after suspension by CDSCO, vows compliance with approved claims.
Read more
2024-09-16 (theprint.in)
Eye drop's claim to replace glasses cost it the launch & sale nod. The controversy & safety concerns
Regulatory approval to Entod Pharma for PresVu, meant to treat presbyopia, was revoked as the firm marketed it as a 'replacement for reading glasses' & due to possible health risks.
Read more
2024-09-11 (ndtvprofit.com)
Government Acts Against PresVu Eye Drop Over Claim To Reduce Dependency On Reading Glasses
The Central Drugs Standard Control Organisation has withdrawn the approval granted to PresVu eye drops, manufactured by Entod Pharmaceuticals, over its claim to reduce dependency on reading glasses.
Read more
(indiatimes.com)
Here is why DCGI has suspended approval of PresVu eye drops that claimed usage would help get rid of reading glasses
Entod Pharmaceuticals had claimed that, "PresVu is the first eye drop in India specifically developed to reduce dependency on reading glasses for individuals affected by presbyopia, a common age-related vision condition that typically impacts those over 40.
Read more